BoonHuey Ee – General Manager, Merck Biopharma Taiwan
BoonHuey Ee, general manager of Merck Biopharma Taiwan, shares her story of joining the affiliate at the beginning of last year and goes on to offer insights on the strengths…
EY is a global leader in professional services, employing 167,000 people in 150 countries and 728 offices around the globe. Their global revenues amounted to US$24.4 billion in financial year 2012. Apart from auditing services, EY also provides advisory services including tax advisory, transaction advisory, internal control, risk management, information technology security, performance improvement and corporate governance, etc. They are recognized for “delivering value” to their clients in different service areas. In 2012, they provided audit, risk management, tax and other advisory services to 80 percent and 63 percent of Fortune Global 500 and Forbes Global 2000 companies, respectively. Their strategy is to use their global professional talent and knowledge to assist their clients to tackle challenges in an ever-changing market environment.
EY Taiwan was established as the first partnership accounting firm in Taiwan, and is an official member of EY. They employ 1,200 professionals across Taiwan by creating the right team in the right place, and provide clients with multi-disciplinary assurance, business advisory, tax and transaction advisory services. Their main office is located in Taipei, with five branch offices in Chungli, Hsinchu, Taichung, Tainan, and Kaohsiung. They have joined EY in China and Hong Kong in forming the Greater China Area to provide clients with comprehensive and efficient services by leveraging their knowledge base and integrated network.
Contact details
Assurance
Based on legitimate professional standards, their assurance, financial report audit, and other value added services assist companies to improve effectiveness and quality.
Assurance Services Leader: Kim Chang / +886-2-2757-8888 #2317
Tax
They help companies navigate the latest tax policies, provide tax assessment and diagnosis, and address potential tax risks.
Tax Services Leader: Heidi Liu / 886-2-2757-8888 #2705
Transactions
They assist clients to evaluate, negotiate, structure, and succeed in transactions by seizing market opportunities to sustain advantageous position and boost growth.
Transaction Advisory Services Managing Director: Jonathan Hsin / +886-2-2757-8888 #1527
Advisory
When major issues strike, their approach helps organizations reduce risks, improve performance, overcome the internal and external challenges, and maximize profits.
Advisory Services Managing Director: Tony Chang / +886-2-2757-8888 #1563
Entrepreneurship
They celebrate entrepreneurs who lead the companies to embed innovation and embrace growth honoring their visions, leaderships, and extraordinary achievements. They present Taiwan entrepreneurship to the world through EY’s global network.
Ernst & Young Foundation / +886-2-2757-8888
BoonHuey Ee, general manager of Merck Biopharma Taiwan, shares her story of joining the affiliate at the beginning of last year and goes on to offer insights on the strengths…
Taiwan’s biotech sector is growing rapidly and increasingly embracing advanced fields such as precision medicine and AI. However, Johnsee Lee, chairman of the Taiwan Bio Industry Organization warns that the island’s…
Rita Huang, dean of the Office of Research and Development and the director of the TMU Research Center for Cell Therapy and Regeneration Medicine highlights the center’s unique capabilities and…
NYMU President Dr Steve Kuo describes the history of the university and transformative period it is currently undergoing. Dr Kuo shares the university’s key strengths and unique strategy to merge…
Dr Michael Chang, founder and chairman of OBI Pharma, shares the history of his company’s beginnings and highlights the current progress of its innovative immune-oncology pipeline. Dr Chang goes on…
Shih-Chung Chen, Minister of Health and Welfare of the Republic of China (Taiwan), gives an update on the Ministry’s current directives under the Biomedical Industry Innovation Program to bolster Taiwan’s…
Dr Hung-Kai Kevin Chen, co-founder and CEO of Elixiron Immunotherapeutics, an innovative rising biotech focused on immunotherapeutic solutions, describes the company’s unique approach to developing new treatment methods for two…
Johnsee Lee, chairman of Taiwan Bio Industry Organization, gives an update on the major developments of the country’s biotech environment over recent years, speaking about its new areas of focus,…
Professor Chi-Hung Lin of NCTU discusses the opportunities and hurdles for unveiling smart healthcare in Taiwan. He also assesses Taiwan’s position in the global race for smart healthcare, and how…
Dar-Bin Shieh, deputy minister of science and technology of the Republic of China (Taiwan), gives an overview of Biomedical Industry Innovation Program, enacted to bolster Taiwan’s biomedical and biotechnology sectors…
Taiwan boasts one of the most sophisticated and comprehensive public health systems in Asia. However, mounting costs and the pressures of a rapidly ageing population mean that the National Health…
Taiwan’s Minister of Economic Affairs, Jong-Chin Shen, outlines the initiatives implemented by the Ministry to help Taiwan’s industries reinforce their competitive advantage. Minister Shen also goes on to explain the…
See our Cookie Privacy Policy Here